Adeona Pharma buys Cali firm, plans to expand in Ann Arbor
Adeona Pharmaceuticals didn’t just open an office in California, it bought one. The Ann Arbor-based firm recently paid handsomely (but smartly) for Colwell Clinical Laboratories in southern California. Adeona plans to use the CLIA-certified clinical laboratory’s services and test it has developed to expand an untapped part of its market.”We’re hoping to increase the type of testing they offer,” says Steve Kanzer, chairman and CEO of Adeona Pharmaceuticals.Kanzer plans to leave Colwell’s five people out in California. In the mean time he hopes to add another 5-10 people to Adeona’s Ann Arbor operations within the next year or two. The company already employs seven people, some independent contractors and the occasional sumer intern. Adeona is a specialty pharmaceutical company specializing in awareness, diagnosis, prevention and treatment of subclinical zinc deficiency and chronic copper toxicity in the mature segment of the population.Source: Steve Kanzer, chairman and CEO of Adeona PharmaceuticalsWriter: Jon Zemke
Adeona Pharmaceuticals didn’t just open an office in California, it bought one.
The Ann Arbor-based firm recently paid handsomely (but smartly) for Colwell Clinical Laboratories in southern California. Adeona plans to use the CLIA-certified clinical laboratory’s services and test it has developed to expand an untapped part of its market.
“We’re hoping to increase the type of testing they offer,” says Steve Kanzer, chairman and CEO of Adeona Pharmaceuticals.
Kanzer plans to leave Colwell’s five people out in California. In the mean time he hopes to add another 5-10 people to Adeona’s Ann Arbor operations within the next year or two. The company already employs seven people, some independent contractors and the occasional sumer intern.
Adeona is a specialty pharmaceutical company specializing in awareness, diagnosis, prevention and treatment of subclinical zinc deficiency and chronic copper toxicity in the mature segment of the population.
Source: Steve Kanzer, chairman and CEO of Adeona Pharmaceuticals
Writer: Jon Zemke
Related Articles
On-Demand Coaching helps Ypsi’s government and small businesses build a winning team
A Michigan Municipal League program helps Ypsi and other municipalities connect small businesses and entrepreneurs with existing capital and technical assistance.
Ann Arbor DDA expands its boundaries for first time, enabling new projects on city’s North Side
The goal of the Ann Arbor Downtown Development Authority’s expansion is to strengthen connections between downtown, the Huron River, and Ann Arbor’s North Side.
Ann Arbor SPARK joins global network of innovation districts
Ann Arbor SPARK has joined The Global Institute on Innovation Districts Global Network, allowing it to collaborate with over 50 innovation districts in 14 countries.
